• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症的选择性治疗:抗生素CC - 1065和双环霉素新型类似物的合成、生物学评价及结构解析

Selective treatment of cancer: synthesis, biological evaluation and structural elucidation of novel analogues of the antibiotic CC-1065 and the duocarmycins.

作者信息

Tietze Lutz F, Major Felix, Schuberth Ingrid, Spiegl Dirk A, Krewer Birgit, Maksimenka Katja, Bringmann Gerhard, Magull Jörg

机构信息

Institut für Organische und Biomolekulare Chemie, Georg-August-Universität Göttingen, Tammannstrasse 2, 37077 Göttingen, Germany.

出版信息

Chemistry. 2007;13(16):4396-409. doi: 10.1002/chem.200700113.

DOI:10.1002/chem.200700113
PMID:17455190
Abstract

Novel diastereomerically pure beta-D-galactosidic prodrugs (+)-12 a-e of the cytotoxic antibiotics CC-1065 and the duocarmycins were prepared for an antibody directed enzyme prodrug therapy (ADEPT) using 4 as a substrate via a radical cyclization to give rac-5 and rac-6 followed by a chromatographic resolution of the enantiomers of rac-5, glycosidation and linkage to the DNA-binding units 10 a-e. These only slightly toxic compounds can be toxified enzymatically by an antibody-beta-D-galactosidase conjugate at the surface of malignant cells to give the cytotoxic drugs, which then alkylate DNA. The new prodrugs were tested in in vitro cytotoxicity assays showing excellent QIC(50) values of 4800 and 4300 for (+)-12 a and (+)-12 b, respectively. The absolute configuration of precursor (+)-5 was determined by comparison of the experimental CD spectrum with the theoretically predicted CD spectra and by X-ray structure analysis.

摘要

制备了细胞毒性抗生素CC - 1065和双卡霉素的新型非对映体纯β - D - 半乳糖苷前药(+)-12 a - e,用于抗体导向酶前药疗法(ADEPT),以4为底物,通过自由基环化反应生成rac - 5和rac - 6,然后通过色谱法拆分rac - 5的对映体,进行糖苷化并与DNA结合单元10 a - e连接。这些毒性仅略微的化合物可在恶性细胞表面被抗体 - β - D - 半乳糖苷酶偶联物酶促转化为细胞毒性药物,进而使DNA烷基化。对新前药进行了体外细胞毒性试验,结果显示(+)-12 a和(+)-12 b的QIC(50)值分别为4800和4300,表现优异。通过将实验性圆二色光谱与理论预测的圆二色光谱进行比较以及X射线结构分析,确定了前体(+)-5的绝对构型。

相似文献

1
Selective treatment of cancer: synthesis, biological evaluation and structural elucidation of novel analogues of the antibiotic CC-1065 and the duocarmycins.癌症的选择性治疗:抗生素CC - 1065和双环霉素新型类似物的合成、生物学评价及结构解析
Chemistry. 2007;13(16):4396-409. doi: 10.1002/chem.200700113.
2
Asymmetric synthesis and biological evaluation of glycosidic prodrugs for a selective cancer therapy.用于选择性癌症治疗的糖苷前药的不对称合成及生物学评价
ChemMedChem. 2008 Dec;3(12):1946-55. doi: 10.1002/cmdc.200800250.
3
Synthesis and biological studies of different duocarmycin based glycosidic prodrugs for their use in the antibody-directed enzyme prodrug therapy.用于抗体导向酶前药疗法的不同基于多卡霉素的糖苷前药的合成与生物学研究
J Med Chem. 2009 Jan 22;52(2):537-43. doi: 10.1021/jm8009102.
4
Synthesis and biological evaluation of prodrugs based on the natural antibiotic duocarmycin for use in ADEPT and PMT.基于天然抗生素柔红霉素的前药的合成及生物评价,用于 ADEPT 和 PMT。
Chemistry. 2011 Feb 7;17(6):1922-9. doi: 10.1002/chem.201002798. Epub 2011 Jan 7.
5
Antibody-directed enzyme prodrug therapy: a promising approach for a selective treatment of cancer based on prodrugs and monoclonal antibodies.抗体导向酶前药疗法:一种基于前药和单克隆抗体的癌症选择性治疗的有前景的方法。
Chem Biol Drug Des. 2009 Sep;74(3):205-11. doi: 10.1111/j.1747-0285.2009.00856.x. Epub 2009 Jul 29.
6
Duocarmycin-based prodrugs for cancer prodrug monotherapy.用于癌症前药单一疗法的基于双环霉素的前药
Bioorg Med Chem. 2008 Jun 15;16(12):6312-8. doi: 10.1016/j.bmc.2008.05.009. Epub 2008 May 7.
7
Synthesis and biological evaluation of novel pyrrolo[2,1-c][1,4]benzodiazepine prodrugs for use in antibody-directed enzyme prodrug therapy.用于抗体导向酶前药疗法的新型吡咯并[2,1-c][1,4]苯并二氮杂卓前药的合成与生物学评价
Bioorg Med Chem Lett. 2006 Jan 15;16(2):252-6. doi: 10.1016/j.bmcl.2005.10.017. Epub 2005 Nov 15.
8
Novel analogues of CC-1065 and the duocarmycins for the use in targeted tumour therapies.用于靶向肿瘤治疗的CC-1065和双霉素的新型类似物。
Anticancer Agents Med Chem. 2009 Mar;9(3):304-25. doi: 10.2174/1871520610909030304.
9
Synthesis and biological evaluation of antibody conjugates of phosphate prodrugs of cytotoxic DNA alkylators for the targeted treatment of cancer.抗体偶联物的合成与生物评价磷酸前药的细胞毒性 DNA 烷化剂为靶向治疗癌症。
J Med Chem. 2012 Jan 26;55(2):766-82. doi: 10.1021/jm201284m. Epub 2012 Jan 5.
10
A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties.一类新型的CC-1065和双霉素的非手性开环类似物:设计、合成、DNA结合及抗癌特性
Bioorg Med Chem. 2004 Dec 1;12(23):6221-36. doi: 10.1016/j.bmc.2004.08.051.

引用本文的文献

1
Luciferase-induced photoreductive uncaging of small-molecule effectors.荧光素酶诱导的小分子效应物光还原解笼。
Nat Commun. 2018 Aug 30;9(1):3539. doi: 10.1038/s41467-018-05916-9.
2
Determination of the biological activity and structure activity relationships of drugs based on the highly cytotoxic duocarmycins and CC-1065.基于高细胞毒性柔红霉素和 CC-1065 测定药物的生物活性和构效关系。
Toxins (Basel). 2009 Dec;1(2):134-50. doi: 10.3390/toxins1020134. Epub 2009 Dec 2.
3
Investigation of the transformations of a novel anti-cancer agent combining HPLC, HPLC-MS and direct ESI-HRMS analyses.
结合高效液相色谱(HPLC)、高效液相色谱-质谱联用(HPLC-MS)和直接电喷雾高分辨质谱(ESI-HRMS)分析对一种新型抗癌药物的转化进行研究。
Anal Bioanal Chem. 2009 Sep;395(2):437-48. doi: 10.1007/s00216-009-2963-x. Epub 2009 Jul 31.
4
Synthesis and biological evaluation of a novel pentagastrin-toxin conjugate designed for a targeted prodrug mono-therapy of cancer.新型五肽胃泌素-毒素偶联物的合成与生物学评价,旨在用于癌症的靶向前药单药治疗。
Int J Mol Sci. 2008 May;9(5):821-837. doi: 10.3390/ijms9050821. Epub 2008 May 20.